Forcing the issue

It’s shocking to get the news that you have type 2 diabetes. But that’s just the start of the shocks you have in store.

Next, you’re in for a stunner when your doctor breaks the bad news… You’ll have to take one or more drugs for the rest of your life.

The tragic irony is that one of those drugs might bring your life to an abrupt end.

Short-term success

Injectable insulin has extended countless lives of type 1 diabetics. But a new study shows that it’s potentially deadly for type 2 patients.

That’s catastrophic news. About one in three type 2 diabetics takes a daily insulin injection. That means millions are at risk.

U.K. researchers examined long-term medical records of more than 84,000 type 2 diabetics. Their results:

Compared to using metformin…

* Insulin use increased risk of a major cardiac event, cancer, or early death by 80%

* Insulin use nearly doubled heart attack risk, and more than doubled neuropathy risk

Patients who took metformin and insulin together were still at greater risk of major cardiac event, cancer, or early death. But that risk was lower than when taking just insulin alone.

Dr. Spreen sent me the details of this study. He noted that in type 1, patients can’t produce their own insulin. In type 2 they can. So for these patients, an insulin injection becomes a battering ram. Insulin is pumped up to such excess that it forces sugar into the cells.

So it works. In the short term.

But insulin use has side effects. These include heart disease, hypertension, and blood disorders. Dr. Spreen’s prediction… If doctors continue treating type 2 with insulin, we’ll see higher rates of death related to heart issues.

Type 2 diabetics should know that in many cases they can manage their disease and even reverse it without drug use.

Recently, I told you about type 2 diabetic Steve Cooksey. In the beginning, his condition was severe. But he dedicated himself to a strict non-carb diet. Within weeks, Steve brought his diabetes under control. Today, he doesn’t use any medications or insulin.

You can find more details of his success at this link.

Sources:
“Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes” The Journal of Clinical Endocrinology & Metabolism, Vol. 98, No. 2, February 2013, jcem.endojournals.org


Recent Articles:

Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >